Global Medical Radiation Detection Market Size, Share, Opportunities, And Trends By Devices (Gas-filled Detectors, Scintillation Detector, Semiconductor Detectors), By Product (Dosimeters, Portal Monitors, Others), By End Users (Hospitals and Clinics, Ambulatory Care Centres, Diagnostic Centres), And By Geography - Forecasts From 2025 To 2030

Global Medical Radiation Detection Market is projected to grow at a CAGR of 4.81% between 2025 to 2030.

Most diagnostic tests use ionizing radiation (eg, x-rays, CT, and radionuclide scanning) and non-ionizing radiation exposure which is potentially harmful and there is no threshold below which no harmful effect occurs, therefore, an effort is made to measure and minimize radiation exposure becomes necessary. Controlled use of radiation has become a key part of modern medical treatment and diagnostics, especially for certain forms of cancer. As a result of the need to regulate radiation exposure, a consistent approach to radiation protection has been taken internationally by the International Commission on Radiological Protection (ICRP) by keeping radiation levels as low as achievable and below the individual dose limits. Growth in the medical radiation detection market may be attributed to the increasing usage of nuclear medicine and radiation therapy for diagnosis and treatment along with the increasing safety awareness among people working in radiation-prone environments. However, a lack of skilled medical physicists might restrain the market for medical radiation market during the given forecast period.

Increasing usage of radiation therapy for cancer treatment.

The market is expected to surge in the coming years, due to the rise in the usage of radiation therapy for various medical purposes. Radiation therapy, which is also known as radiotherapy, is a cancer treatment that uses a wide and considerable range and doses of radiation, to shrink tumours and kill cancer. With the rising cases of cancer, the demand for radiation therapy is expected to surge. According to the World Health Organisation, cancer has become a leading cause of mortality and death, and amounted to around 10 million deaths, in the year 2020. Radiation therapy has become an imperative mechanism to ease cancer symptoms and treat cancer. It is used to cure cancer, slow or stop its growth and prevent it from returning. External and internal radiation therapy is used to treat different types of cancer. Brachytherapy is one of the most common procedures to treat cancers of the neck and head, eye, prostate, and cervix. Systematic radiation therapy is used to treat different types of thyroid cancer. Other types of systematic radiation therapy, such as targeted radionuclide therapy, are also used to cure and treat patients with gastroenteropancreatic neuroendocrine tumours or advanced prostate cancer. These developments and trends are expected to play a major role in the overall market growth, in the coming years.

Latest Developments.

Major companies have been investing a significant sum of capital into research and development, innovation, advancement, investment, and novel product launches. 

• In June 2021, Elekta, one of the major players in the market, announced that its major flagship Harmony radiation therapy system had received clearance from the United States of Food and Drug Administration (FDA), which would allow the US clinics to use and harness the novel system for treating a wide range of indications using the novel, advance, and latest radiotherapy techniques.
• In June 2021, UNC Health Southeastern's Gibson Center announced that it had added a novel, advanced, state-of-the-art system and technology from C-RAD to allow safer radiation treatments to more cancer patients and enhance their overall quality of life. The novel system was selected to provide innovatively and advanced radiation treatment technology with the highest level of safety and accuracy. This development is expected to have a major impact on the market, in the coming years.

Increasing usage of nuclear medicine.

The market is expected to surge in the coming years, due to the surging use of nuclear medicines, globally. Major regions have been making a significant impact in the market, in the past few years. In June 2021, it was reported that Europe is expected to make a substantial impact in the market, in the coming years. The joint paper from the European nuclear trade body, Nuclear Medicine Europe and Foratom, which represents imaging equipment and pharmaceutical companies, stated that Europe must take extensive measures and initiatives to maintain the current level of radioisotope supply. The joint paper also stated that the European Union must promote novel research reactor capacity installations, along with innovation in the design modification and the sector. There have been other developments in the nuclear medicine market, in the last few years. For instance, in June 2021, The Center of Molecular Imaging and Theagnostic Therapy announced that they had opened a novel cutting-edge nuclear centre in Rivonia, which is expected to enhance the market growth in South Africa. The team of doctors operating in the centre stated that the novel nuclear medicine would play an imperative role in the accurate treatment and diagnosis of critical and major diseases, such as cancer.

Segmentation:

• By Devices
  • Gas-filled Detectors
  • Scintillation Detector
  • Semiconductor Detectors
• By Product
  • Dosimeters
  • Portal Monitors
  • Others
• By End Users
  • Hospitals & Clinics
  • Ambulatory Care Centers
  • Diagnostic Centers
• By Geography
  • North America
    • USA
    • Canadá
    • Mexico
  • South America
    • Brazil
    • Argentina
    • Others
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Others
  • Middle East and Africa
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Thailand
    • Taiwan
    • Indonesia
    • Others

Biodex Medical Systems

Jefferson Lab Radiation Detectors & Imaging Group

Excelitas Technologies Corp.

Ludlum Measurements Inc.

AMETEK Inc.

Arktis Radiation Detectors Ltd.

Kromek Group Plc

Polimaster Ltd.

Thermo Fisher Scientific

Landauer